Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medication ap...

Ovid stops preclinical work, IV system after soticlestat fall short

.Ovid Therapy currently showed final month that it was actually trimming its head count as the busin...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston ma Port, boosting its RNA ...

Boundless Bio produces 'modest' discharges five months after $100M IPO

.Simply 5 months after safeguarding a $one hundred thousand IPO, Boundless Biography is currently la...

Halda's $126M will certainly accelerate 'hold and also get rid of' cyst drugs

.The first phases of oncology R&ampD may not be short of interesting brand-new modalities, as well a...

Lykos 'remorses' not making known study transgressions with author

.Psychopharmacology has actually pulled 3 short articles concerning midstage clinical test records e...

Analysts dig into Avidity's DMD succeed, uncovering nuances in records

.Avidity Biosciences impressed real estate investors along with phase 1/2 records in Duchenne muscul...

Actinogen's cortisol blocker neglects stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a stage 2 research i...

Bivictrix chooses going exclusive only technique to take ADC into center

.Antibody-drug conjugates (ADCs) have actually been at the facility of lots of a billion-dollar biob...

TPG tops up funds to $580M for expenditures throughout lifestyle scientific researches

.Property supervisor TPG, which has actually sustained biotechs including Sionna Rehabs as well as S...